Publication
Essential Corporate News – Week ending 8 November 2024
On 6 November 2024, the Home Office published guidance under section 204 Economic Crime and Corporate Transparency Act 2023 (ECCTA).
In this edition of Insurance Focus, we have asked colleagues across the firm to describe the issues that they think are having the greatest impact on their local insurance industry. Technology and the rise of InsurTech are common factors having an effect on insurers as is the growing demand for cyber cover as attacks become more frequent. In a number of countries, increased regulation and costs of compliance are the main factors changing the operational landscape.
We consider changes to the minimum corporate governance standards for Hong Kong based insurers and review the impact of “nil-recourse” M&A deals on the warranty and indemnity insurance market.
We also provide a review by marine insurance lawyer WenHao Han of the recent Gard Marine decision by the UK Supreme Court, while UK Court of Appeal decision Ashfaq raises interesting questions about the blurred lines between acting as a consumer or a business and the resulting impact on coverage.
Publication
On 6 November 2024, the Home Office published guidance under section 204 Economic Crime and Corporate Transparency Act 2023 (ECCTA).
Publication
On 6 November 2024, the UK Takeover Panel (Panel) published response statement RS 2024/1 - Companies to which the Takeover Code applies (Response Statement) setting out final rule changes that will result in a refocusing and significant narrowing of the types of companies subject to the UK Takeover Code (Code). This follows on from the Panel’s previous consultation on this topic in April 2024.
Publication
On 01 August 2024, the European Commission (EC) launched a public consultation on the draft text of the Guidelines on the application of Article 102 TFEU to abusive exclusionary conduct by dominant undertakings (the draft Guidelines).
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023